LIFE
Companies
NASDAQ
aTyr Pharma Inc
Health Care
$5.17
+$1.26 (+32.23%)
Price Chart
Overview
About LIFE
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
Market Cap
$119.4M
Volume
3.0M
Avg. Volume
2.1M
P/E Ratio
-2.5333333
Dividend Yield
0.00%
Employees
69.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.21
Moderate Correlation
Volatility
High (0.79)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, LIFE shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$119.4M
Volume3.0M
P/E Ratio-2.53
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
August 10, 2023Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025